Discontinued — last reported Q3 '25

Current Liabilities

Operating Lease Liability Payments Due

West Pharmaceutical Services Operating Lease Liability Payments Due increased by 31.2% to $140.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.4%, from $113.70M to $140.30M. Over 3 years (FY 2020 to FY 2023), Operating Lease Liability Payments Due shows an upward trend with a 11.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ3 2025

How to read this metric

Rising liabilities indicate growing operational footprint or lease renewals, while falling liabilities may signal cost-cutting or consolidation of facilities.

Detailed definition

This represents the total future cash payments required for operating leases, typically categorized by maturity periods...

Peer comparison

Standardized under ASC 842, this metric is highly comparable across all public companies with significant physical operations.

Metric ID: operating_lease_liability_payments_due

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$78.60M$74.10M$86.40M$93.70M$95.20M$104.40M$126.70M$123.20M$119.90M$115.50M$118.10M$115.70M$119.90M$116.40M$113.70M$113.50M$106.90M$140.30M
QoQ Change-5.7%+16.6%+8.4%+1.6%+9.7%+21.4%-2.8%-2.7%-3.7%+2.3%-2.0%+3.6%-2.9%-2.3%-0.2%-5.8%+31.2%
YoY Change+21.1%+40.9%+46.6%+31.5%+25.9%+10.6%-6.8%-6.1%+0.0%+0.8%-1.7%-5.3%-8.2%+23.4%
Range$74.10M$140.30M
CAGR+14.6%
Avg YoY Growth+12.3%
Median YoY Growth+5.7%

Operating Lease Liability Payments Due at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's operating lease liability payments due?
West Pharmaceutical Services (WST) reported operating lease liability payments due of $140.30M in Q1 2026.
How has West Pharmaceutical Services's operating lease liability payments due changed year-over-year?
West Pharmaceutical Services's operating lease liability payments due increased by 23.4% year-over-year, from $113.70M to $140.30M.
What is the long-term trend for West Pharmaceutical Services's operating lease liability payments due?
Over 3 years (2020 to 2023), West Pharmaceutical Services's operating lease liability payments due has grown at a 11.5% compound annual growth rate (CAGR), from $85.20M to $118.10M.
What does operating lease liability payments due mean?
The total future cash payments the company is contractually obligated to make for operating leases.